DT
PBYI icon

Diversified Trust’s Puma Biotechnology PBYI Stock Holding History

Diversified Trust’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,175
Closed -$48K – 840
2022
Q3 		$48K Hold
20,175
– – ﹤0.01% 749
2022
Q2 		$57K Sell
20,175
-5,461
-21% -$13.6K ﹤0.01% 729
2022
Q1 		$74K Sell
25,636
-52
-0.2% -$135 ﹤0.01% 783
2021
Q4 		$78K Buy
25,688
+6,053
+31% +$26.3K ﹤0.01% 814
2021
Q3 		$138K Sell
19,635
-7,235
-27% -$54.2K 0.01% 752
2021
Q2 		$247K Buy
26,870
+15,218
+131% +$154K 0.01% 623
2021
Q1 		$113K Sell
11,652
-2,065
-15% -$23.1K ﹤0.01% 726
2020
Q4 		$141K Buy
+13,717
New +$139K 0.01% 694

Other funds holding PBYI

CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return